Axsome Therapeutics AXSM Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $8.65B.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's market capitalization?
- Axsome Therapeutics (AXSM) reported market capitalization of $8.65B in Q1 2026.
- How has Axsome Therapeutics's market capitalization changed year-over-year?
- Axsome Therapeutics's market capitalization increased by 52.0% year-over-year, from $5.69B to $8.65B.
- What is the long-term trend for Axsome Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Axsome Therapeutics's market capitalization has grown at a 24.7% compound annual growth rate (CAGR), from $3.05B to $9.21B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.